IP Library Granted Patent US 10,851,128
Granted Patent B2
US 10,851,128 · App. 16/393,859 · Granted Dec 1, 2020

Hydrated and anhydrous polymorphs of 2′-O-fucosyllactose and their production methods

Inventors: Giovanni Cipolletti (Milan, IT); Gessica Laudati (Scandicci, IT); Liana Salsini (Seravezza, IT); Michael Puhl (Ludwigshafen, DE)
Assignee: BASF SE
C07H3/06A23L33/125C07H1/00A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,851,128
App. No.
16/393,859
Granted
Dec 1, 2020
Kind
B2
Abstract

This invention describes new hydrated and anhydrous polymorphs of 2′-0-ficosyllactose (2′FL): Polymorph A 2′FL-3/2H 2 O, Polymorph B 2TL-5/2H 2 O and anhydrous Polymorph C. There is also a description of the methods for obtaining them, and of a new method for preparing Polymorph I already known in the literature.

Claims (23)

1. 2′-O-Fucosyllactose (2′FL) in anhydrous crystalline form of polymorph C, wherein said polymorph C has characteristic XRPD peaks at 17.58±0.20, 17.44±0.20, 10.63±0.20 2Θ.

2. A polymorph C according to claim 1 , having characteristic XRPD peaks at 17.58±0.20, 17.44±0.20, 10.63±0.20, 5.30±0.2, 20.05±0.20 2Θ.

3. A polymorph C according to claim 1 , wherein the single crystal is arranged within a monocline system and the elementary cell has the following parameters: a=5.058(1) Å, b=12.773(3) Å, c=16.692(5) Å and a volume of 1074.75 Å 3 .

4. A method for preparing the polymorph C according to claim 1 , the method comprising crystallizing 2′FL from a C 1 -C 4 alcohol or mixtures thereof.

5. A method for obtaining crystalline 2′-O-Fucosyllactose (2′FL) anhydrate in form of polymorph C with molecular formula C 18 H 32 O 15 , the method comprising:

providing a mixture comprising (i) a C 1 -C 3 alcohol or mixture thereof and (ii) a 2′FL hydrate in form of polymorph A with molecular formula C 18 H 32 O 15 .nH 2 O wherein n is 3/2; and

warming the mixture at a temperature in range of 30° C. to 70° C. for 1 hr to 24 hr, thereby crystallizing the 2′FL and forming 2′FL anhydrate in form of polymorph C crystals suspended in the mixture.

6. The method of claim 5 , further comprising:

cooling the mixture; and

separating polymorph C crystals from the mixture to collect solid polymorph C crystals.

7. The method of claim 6 , comprising cooling the mixture to a temperature in a range of 10° C. to 15° C.

8. The method of claim 5 , wherein the C 1 -C 3 alcohol comprises methanol.

9. The method of claim 5 , comprising warming the mixture at a temperature in range of 60° C. to 65° C. for 1 hr to 4 hr.

10. The method of claim 5 , wherein the polymorph A has characteristic XRPD peaks at 18.86±0.20, 9.89±0.20, and 17.05±0.20 2Θ.

11. The method of claim 5 , wherein the polymorph A has characteristic XRPD peaks at 18.86±0.20, 9.89±0.20, 17.05±0.20, 21.65±0.20, and 14.20±0.20 2Θ.

12. The method of claim 5 , wherein a single crystal of the polymorph A has a P2 1 2 1 2 1 spatial group which is arranged within an orthorhombic crystalline system and the crystal comprises elementary cells having the following parameters: a=12.4098(8) Å, b=12.737(2) Å, c=13.756(2) Å and a volume of 2212.5 Å 3 .

13. The method of claim 5 , wherein the polymorph A has a β anomeric conformation.

14. The method of claim 5 , wherein the polymorph A has a predominantly β anomeric conformation with an α anomer content of less than 15%.

15. The method of claim 5 , wherein the polymorph C has characteristic XRPD peaks at 17.58±0.20, 17.44±0.20, and 10.63±0.20 2Θ.

16. The method of claim 5 , wherein the polymorph C has characteristic XRPD peaks at 17.58±0.20, 17.44±0.20, 10.63±0.20, 5.30±0.20, and 20.05±0.20 2Θ.

17. The method of claim 5 , wherein a single crystal of the polymorph C is arranged within a monocline system and the elementary cell has the following parameters: a=5.058(1) Å, b=12.773(3) Å, c=16.692(5) Å and a volume of 1074.75 Å 3 .

18. The method of claim 5 , wherein the polymorph C has a β anomeric conformation.

19. The method of claim 5 , wherein the polymorph C has a predominantly β anomeric conformation with an α anomer content of less than 15%.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2026
From: BASF SE
To: DSM-FIRMENICH SWITZERLAND AG
Reel/Frame 075726/0732 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2026
From: DSM-FIRMENICH SWITZERLAND AG
To: DSM IP ASSETS B.V.
Reel/Frame 075726/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2019
From: PUHL, MICHAEL
To: BASF SE
Reel/Frame 051018/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2019
From: CIPOLLETTI, GIOVANNI; LAUDATI, GESSICA; SALSINI, LIANA
To: INALCO S.A.S. DI GIOVANNI CIPOLLETTI & C.
Reel/Frame 051018/0926 →
CHANGE OF NAME Recorded Nov 15, 2019
From: INALCO S.A.S. DI GIOVANNI CIPOLLETTI & C.
To: INALCO S.R.L.
Reel/Frame 051019/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2019
From: INALCO S.R.L.
To: BASF SE
Reel/Frame 051019/0170 →
Priority Claims (1)
IT FI2012A0143 · Jul 12, 2012 · national
Continuity (2)
Division 14655470
Related Publication 20200048294A1 · Feb 13, 2020